Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — H1 2020 Earnings Presentation
10 slides from Rhon-klinikum's earnings presentation, Aug 6, 2020
Slide 1: First Half-Year 2020 Results
First Half-Year 2020 Results 6 August 2020 RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by RHÖN-KLINIKUM AG (the “Company”) and is for information purposes only. This presentation does not constitute, or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwrite or otherwise acquire, any
Slide 3: Key aspects of H1 2020: Takeover bid by Asklepios
Key aspects of H1 2020 Takeover bid by Asklepios Asklepios has successfully completed the voluntary public takeover bid. RHÖN will remain a stock-listed and independent company. Management Board of RHÖN welcomes the new partnership with Asklepios. Together with Asklepios, RHÖN can make an ev
Slide 4: Key aspects of H1 2020: COVID-19 Pandemic
Key aspects of H1 2020 COVID-19 Pandemic* The fact that the care of all patients has been successful in this exceptional situation is due to the dedicated commitment of our employees at all clinic locations, who have shown team spirit, commitment and great compassion for all patients and their rel
Slide 5: Key P&L figures First Half-Year of 2020
Key P&L figures First Half-Year of 2020* Performance vs. Figures for the first half of 2020 are only conditionally H1 2020 comparable to the same period of the previous year: in € millions H1 2019 Revenue 670.5 100.0% 4.1% o Revenues include COVID-19 compensation payments of € 50.8m. Further deviati
Slide 6: Core balance sheet positions as of June 2020
Core balance sheet positions as of 30 June 2020 € 1,634m € 1,634m € 1,052m 64.4% Non-current assets € 1,185m 72.5% Equity € 582m Current assets € 20m Non-current liabilities 1.3% 35.6% of which € 429m € 272m Cash Current liabilities 26.2% & fixed term deposits Assets Equity & liabilities Solid balan
Slide 7: Outlook 2020
Outlook 2020 GUIDANCE Group REVENUES € 1.4bn +/- 5% 2020 Group EBITDA € 72.5m to € 82.5m Focus on economic management of the COVID-19 pandemic The corona pandemic will remain the dominant challenge for the healthcare sector for the rest of 2020. Even though RHÖN-KLINIKUM AG is in a sound economic po
Slide 8: Dividend Proposal
Dividend Proposal GUIDANCE 2020 Amended dividend proposal in light of the COVID-19 pandemic Against the background of the economic challenges and the continuing uncertainties regarding the further effects of the COVID 19 pandemic, the high compensation payments of € 51.6m (as of 30 June 2020) to dat
Slide 9: Appendix: Shareholder structure
Appendix Shareholder structure* After completion of the takeover bid and contribution of 92.27% of the voting rights in RHÖN to AMR, Asklepios and 6.62% Dr. Bernard gr. Broermann Free float together with Eugen Münch hold a total of 93.38% of the voting rights in RHÖN (as of 24 July 2020). RHÖN Share
Slide 10: IR Contact & Financial Calendar
IR Contact & Financial Calendar IR Contact Financial Calendar upcoming events in 2020 Julian Schmitt Head of Investor Relations & Treasury 19 August 2020 Virtual Annual General Meeting tel +49 9771 65 12250 6 November 2020 email ir@rhoen-klinikum-ag.com Publication of Q3 financial report 2020 RH